Bundling drugs as part of reimbursement for episodes of care is an approach to holding down health care spending that is worth considering, policymakers said at a recent Bipartisan Policy Center event. CMS listed drug-pay bundles as an approach to explore during the second phase of the proposed Part B drug demonstration, the first phase of which faces strong opposition. CMS for decades has bundled payments for provider services, starting with the Diagnosis Related Group system that pays for hospital...